188 related articles for article (PubMed ID: 26059710)
1. Progress and prospects of endothelial progenitor cell therapy in coronary stent implantation.
Lan H; Wang Y; Yin T; Wang Y; Liu W; Zhang X; Yu Q; Wang Z; Wang G
J Biomed Mater Res B Appl Biomater; 2016 Aug; 104(6):1237-47. PubMed ID: 26059710
[TBL] [Abstract][Full Text] [Related]
2. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
3. Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis.
Park KS; Kang SN; Kim DH; Kim HB; Im KS; Park W; Hong YJ; Han DK; Joung YK
Acta Biomater; 2020 Jul; 111():91-101. PubMed ID: 32434081
[TBL] [Abstract][Full Text] [Related]
4. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
[TBL] [Abstract][Full Text] [Related]
5. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
[TBL] [Abstract][Full Text] [Related]
6. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
[TBL] [Abstract][Full Text] [Related]
7. Mussel adhesive protein fused with VE-cadherin extracellular domain promotes endothelial-cell tight junctions and in vivo endothelization recovery of vascular stent.
Yang D; Yan W; Qiu J; Huang Y; Li T; Wang Y; Wang N; Durkan C; Huang J; Yin T; Wang G
J Biomed Mater Res B Appl Biomater; 2020 Jan; 108(1):94-103. PubMed ID: 30974041
[TBL] [Abstract][Full Text] [Related]
8. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
9. Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis.
Lev EI; Leshem-Lev D; Mager A; Vaknin-Assa H; Harel N; Zimra Y; Bental T; Greenberg G; Dvir D; Solodky A; Assali A; Battler A; Kornowski R
Eur Heart J; 2010 Nov; 31(21):2625-32. PubMed ID: 20543191
[TBL] [Abstract][Full Text] [Related]
10. Controlled release of paclitaxel using a drug-eluting stent through modulation of the size of drug particles in vivo.
Jang BN; Kang SN; Eom TG; Han DK; An SH; Noh I; Kum CH
J Biomed Mater Res B Appl Biomater; 2018 Aug; 106(6):2275-2283. PubMed ID: 29087014
[TBL] [Abstract][Full Text] [Related]
11. Development of in vitro endothelialized drug-eluting stent using human peripheral blood-derived endothelial progenitor cells.
Tsukada J; Wolf F; Vogt F; Schaaps N; Thoröe-Boveleth S; Keijdener H; Jankowski J; Tsukada H; Jockenhövel S; Jinzaki M; Schmitz-Rode T; Mela P
J Tissue Eng Regen Med; 2020 Oct; 14(10):1415-1427. PubMed ID: 32668066
[TBL] [Abstract][Full Text] [Related]
12. Direct surface modification of metallic biomaterials via tyrosine oxidation aiming to accelerate the re-endothelialization of vascular stents.
Kakinoki S; Takasaki K; Mahara A; Ehashi T; Hirano Y; Yamaoka T
J Biomed Mater Res A; 2018 Feb; 106(2):491-499. PubMed ID: 28975703
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.
Berta B; Jambrik Z; Kohar K; Szabo G; Ruzsa Z; Molnar L; Barczi G; Geller L; Becker D; Merkely B
Hellenic J Cardiol; 2014; 55(5):369-77. PubMed ID: 25243435
[TBL] [Abstract][Full Text] [Related]
14. High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility.
Vanags LZ; Wong NKP; Nicholls SJ; Bursill CA
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1691-1701. PubMed ID: 29954755
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Progenitor Cells and In-stent Restenosis.
Xu BY; Xiang MX; Wang JA
Curr Stem Cell Res Ther; 2015; 10(4):364-71. PubMed ID: 25654305
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of restenosis and novel issues of drug-eluting stents.
Inoue T; Node K
Circ J; 2009 Apr; 73(4):615-21. PubMed ID: 19282604
[TBL] [Abstract][Full Text] [Related]
17. Bilirubin coating attenuates the inflammatory response to everolimus-coated stents.
Bae IH; Park DS; Lee SY; Jang EJ; Shim JW; Lim KS; Park JK; Kim JH; Sim DS; Jeong MH
J Biomed Mater Res B Appl Biomater; 2018 May; 106(4):1486-1495. PubMed ID: 28691192
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
